Candida albicans public proteomic datasets, though growing steadily in the last few years, still have a very limited presence in online repositories. We report here the creation of a C. albicans 
1.

Introduction
Candida albicans is a fungus of great clinical importance. In addition to asymptomatically colonizing mucous membranes as a commensal in a large percentage of the population, it may cause severe opportunistic infections in specific cases such as patients with weakened immune defenses, a common circumstance in cancer and AIDS patients. C. albicans infections are also a threat to patients in post-surgical situations and intensive care unit stays. In this respect, invasive candidiasis remains nowadays one of the major types of nosocomial infections and a challenge in terms of economical and health costs [1] [2] [3] . From the perspective of proteomics, recent studies have provided new insights into the C. albicans biology and suggested new clinical biomarker candidates for diagnosis and prognosis of invasive candidiasis [4] [5] [6] [7] .
However, the clinical relevance of this organism is not reflected in the number of large-scale publicly available proteomics resources. Up to the current date, the PRIDE [8] database includes only 15 experiments accounting for 1786 identified proteins. The more C. albicans-focused Proteopathogen database [9] comprises several hundred protein identifications including data from gel based proteomics, and other major proteomic online resources such as the Global Proteome Machine Database (GPMDB [10] ) or Tranche [11] contain no C. albicans data whatsoever.
As for the genomic data, according to Candida Genome Database (CGD), currently the most comprehensively annotated C. albicans sequence repository [12] , the C. albicans genome contains 6215 ORFs (as of May 28, 2013) , out of which 1497 are annotated as verified, i.e. representing genes for which there is empirical evidence that the ORF actually encodes a functionally characterized protein. In contrast, 4566 ORFs are termed uncharacterized, indicating that there exists no conclusive evidence for the existence of a protein product. This data implies that most part of the predicted proteome, over 70% of the ORFs, is still unknown or has not been properly annotated yet. An extensive characterization of the C. albicans proteome will therefore be of great value to increase our knowledge in proteins involved in mechanisms of virulence and infection and, thus serves as a basis to design strategies for diagnosis, vaccination and treatment of invasive candidiasis.
Since its inception, the PeptideAtlas project [13] has encouraged mass spectrometry data submission by the community and has thus grown to a large compilation of atlases of different species including human tissue and body fluid specific builds (brain, plasma [14] and urine), microbial builds (Halobacterium [15] , Mycobacterium tuberculosis [16] , Streptococcus [17] , Leptospira, Plasmodium [18] , Saccharomyces [19] and Schizosaccharomyces [20] ); invertebrate builds (Caenorhabditis elegans, Drosophila [21] and Apis mellifera [22] ); and a pig and a bovine milk [23] builds. The PeptideAtlas project, as a multi-species compendium of proteomes, is continuously increasing its biological diversity. The recent Schizosaccharomyces pombe atlas [23] attains a large coverage of its proteome by ad hoc extensive fractionation and high-resolution LC-MS/MS, and contributes in the sense that some of the fission yeast biological processes have a high degree of conservation with the corresponding pathways in mammalian cells. The incorporation of C. albicans resolves the previous absence of fungal pathogens in the PeptideAtlas and their under representation in any public proteomic data repository.
Furthermore, the proven utility of PeptideAtlas as a resource for selecting proteotypic peptides for Selected Reaction Monitoring (SRM) [24] or SWATH-MS [25] will enable a starting point for future targeted proteomics workflows in C. albicans.
2.
Material and methods
Empirical data compilation
Large amounts of mass spectrometry data corresponding to many and diverse measurements of the C. albicans proteome initially intended for different purposes were assembled in order to build the PeptideAtlas. A range of proteomic methods, protocols and different biological conditions were used to generate the data as shown in Table 1 . These include membrane protein extractions [26] , morphological yeast to hypha transition experiments [27] and phosphoprotein enrichment treatments. The combination of these diverse datasets resulted in an unprecedented overall coverage of the C. albicans proteome. Protein samples were obtained as previously described in [27] . Briefly, cells of the clinical isolate SC5314 were grown in YPD medium for standard growth, whereas hyphal form growth was induced using either Lee medium pH 6.7 or heat-inactivated fetal bovine serum. Protein extracts were then obtained by mechanical cell disruption using either glass beads in the MSK cell homogenizer or the Fast-Prep cell breaker. Protein digests were obtained by trypsinization and separated via HPLC. All spectra acquisition runs were performed by LC-MS/MS in a datadependent manner in different instruments and setups. Table 1 provides an overview of the experiments along with the instruments used for the mass spectrometry and the corresponding number of raw spectra data files that were acquired. In addition, raw MS data from unpublished, SILAC labeled and phosphoprotein enriched samples generated from studies focused on Candida interaction with host immune cells and from experiments studying the hyphal and yeast-form proteomes, were added to the collection.
Peptide and protein identification
PeptideAtlas ensures consistency and quality of the stored data by processing the raw spectra sets by the Trans-Proteomic Pipeline (TPP) [28] , a suite of software tools for processing shotgun proteomic datasets. The TPP tools are run in a wellestablished sequential pipeline spanning steps from creating appropriate standard files to be used as input by the search engine to statistical validation of protein inference and calculation of the False Discovery Rate (FDR). The collected raw spectra files in different proprietary file formats were converted to the standard format for mass spectrometry output data mzML [29] , searched using X!Tandem [30] with the K-score algorithm plug-in [31] and the output search results were converted to the search engine-independent pepXML format [32] .
The target fasta sequence file used for the search was obtained from the Candida Genome Database (CGD) [12] at: http://www.candidagenome.org/download/sequence/C_ albicans_SC5314/Assembly21/.
Common contaminants from the common Repository of Adventitious Proteins (cRAP) were appended. Then for each of these sequences, counterpart reversed decoy sequences were appended. PeptideProphet [33] was then run on the search results to model the distributions of correctly and incorrectly assigned Peptide-to-Spectrum Matches (PSMs). It then assigns probabilities of being correct for each PSM, yielding a sensitive and flexible approach to report results in a comparable manner. Next, iProphet [34] was used to combine additional sources of evidence including multiple identifications of the same peptide across spectra, experiments, and charge and modification states, allowing a more precise integration of evidence supporting the identification of each unique peptide sequence. ProteinProphet [35] was then run to refine iProphet probabilities by adding the information at the protein level, like the number of sibling peptides within a protein and to compute final protein level probabilities. The prophet tools together combine multiple layers of evidence and refine the model iteratively to achieve an optimal analysis of the data. Finally MAYU [36] estimated FDR at different levels for each contributing experiment and for the entire dataset based on the PSMs to decoy proteins.
This process followed the pipeline first implemented in the construction of the human plasma PeptideAtlas described in [14] and successfully applied to other builds such as the bovine milk and mammary gland PeptideAtlas [23] .
Construction of the PeptideAtlas
The PeptideAtlas building process calculates the cumulative number of identified peptide and proteins across the experiments, gathers information on protein to genome location mappings and estimates the peptides' Empirical Suitability Score and Predicted Suitability Score (ESS and PSS). The genomic mappings, since C. albicans is not present in the Ensembl database, which is the default PeptideAtlas uses to that purpose, were extracted from a generic feature file located at the following url: http://www.candidagenome.org/download/gff/C_albicans_SC531 4/C_albicans_SC5314_version_A21-s02-m05-r10_features.gff. An overview of how the different experiments contribute, in terms of the number of identified spectra and peptides, to the atlas build is depicted in Fig. 1 .
Besides, and due to the particularly rich number of identifications in experiments aimed at the detection of phosphorylated proteins (experiments #3 to #13), a similarly processed version of the PeptideAtlas was created including in this case PTMProphet results which provide, alongside each modified residue, the probability that the post-translational modification is truly detected at that site.
3.
Results and discussion
Assessment of proteome coverage and functional enrichment analysis
The assembled proteomic datasets (Table 1) were subject to uniform data processing in order to build the C. albicans Table 1 .
PeptideAtlas. The PSM assignment and protein inference processes were conducted by means of the consistent and robust pipeline TPP. The prophet tools integrate various levels of information and report identification results in statistical terms so that spectrum assignments, peptide to protein mappings and protein groups are statistically validated, leading to an overall improved sensitivity for a defined FDR level. As a result the generated C. albicans PeptideAtlas comprises 21,938 peptides identified at a 0.24% FDR allocated to 2562 proteins at a 1.2% FDR, that is, a coverage of 41.3% of the 6209 C. albicans translated ORF sequences from the fasta database used for searches. While the presented instance of the C. albicans PeptideAtlas has reached unprecedented coverage, it does not represent a final representation of the respective proteome. Like other PeptideAtlas instances for other species, the C. albicans atlas will be expanded upon submission and processing of new MS data generated in ongoing projects.
To determine the biological functions encompassed by the covered part of the proteome in this PeptideAtlas a Gene Ontology (GO) annotation enrichment analysis was carried out for the list of all detected C. albicans canonical proteins, excluding decoy hits, using the biological process ontology and Genecodis software [37] . Predictably, it generated a diverse array of clusters heterogeneously annotated, among which the largest in number of proteins are associated with the GO terms oxidation-reduction process, cellular response to drug, pathogenesis and hyphal growth respectively (Fig. 2) . The enrichment in some very generic GO terms such as oxidation-reduction process, cellular response to drug and translation supports the hypothesis that the diversity of experiments assembled to build the atlas provides a representative, unbiased subset of the C. albicans proteome. In contrast, the more precise groups resulting from the analysis related to pathogenesis, hyphal growth and fungal-type cell wall organization are consistent with the large contribution to the atlas by the experiment aimed at identifying proteins from cells in hyphal form and by the profusion of these sort of annotations in the source database.
As for the set of proteins present in the fasta database used for the searches that are not covered in the PeptideAtlas, they were subject to a similar analysis and were found to be enriched in annotations related to the transmembrane transport GO term (Fig. 2) . These proteins are not easily observed by LC-MS/MS techniques as previously reported [20] . Also, we observed enrichment in regulation of transcription, DNA-dependent in the undetected part of the proteome. Given the short life span and low abundance of many transcription factors it is plausible that they were not detected in the collected datasets and their under representation in proteomic data has also been reported in other proteomic studies and in PeptideAtlas instances from other species [20, 38, 39] . The low number of protein groups significantly associated with GO annotations in the undiscovered set is understandably due to the fact that 2460 out of 3665 of the undetected protein sequences, roughly two thirds, correspond to unnamed ORFs, meaning, that little is known about their biological function.
In addition to the groups of functionally characterized proteins, this PeptideAtlas offers solid empirical evidence for the existence of 1564 proteins, showing a ProteinProphet probability score greater than 0.9, corresponding to uncharacterized ORFs in the CGD database (i.e., one-third of all 4566 uncharacterized ORFs).
Proteins of interest. Case of use
From the clinical angle, the characterization of the C albicans proteome is focused on particular subproteomes, including cell surface constituents, and the set of proteins involved in the yeast-to-hypha transition. The cell wall, as the outermost cell structure represents the contact surface with host cells and therefore gathers many antigens, virulence factors and Pathogen Associated Molecular Patterns (PAMPs) [40] . Proteins Fig. 2 -Gene Ontology annotation enrichment analysis for both the covered and undetected proteome subsets. All shown GO annotations correspond to the biological process ontology and were found significant for a p-value cut-off below 0.01.
involved in hyphal growth are also relevant in pathogenesis, in the sense that hyphae have been proven as key for invasiveness whereas the switch back to yeast form plays a role in dissemination [41] . Within these groups, a selected set of proteins of interest present in the atlas, are the adhesins from the ALS family with a role in invasiveness Als2p and Als3p; those required for cell wall biogenesis and organization glycosidases Phr1p, Phr2p and Utr2p; mannosyltransferases Pmt1p, Pmt4 and Pmt6; those involved in the cell-wall glucan metabolism Mp65p and Ecm33p, and the hyphal cell wall constituents Hwp1, Csp37p and Rbt1p.
Other relevant proteins in the atlas are the ones related to apoptosis, since those would make an ideal target for the treatment of invasive candidiasis. Among those, the atlas contains Mca1p, Bcy1p, Ras1p and three unnamed ORFs with orthologous in other species showing roles in the apoptotic process (orf19.713, orf19.967 and orf19.7365).
For any particular proteins of interest, the PeptideAtlas web interface provides tools to explore the data. A user can Fig. 3 -Protein-and peptide-centric views for Bgl2p are depicted. Distinct observed peptides are ranked by the BestProb parameter (representing the PeptideProphet probability). Of those, most probably, some will also be present in the following Predicted Highly Observable Peptides table were peptides are ranked by PSS, a combination of different prediction algorithms. For all observed peptides, spectra from the different experiments are also available.
browse through a set of protein and peptide-centric views as illustrated in Fig. 3 for the specific case of Bgl2p, a cell wall glucosyltransferase. Its corresponding observed peptides are highlighted in the protein sequence and sorted by the Empirical Suitability Score (ESS), which represents the proportion of the number of samples in which the peptide is observed with regard to the number of samples in which the original protein is observed. This parameter, in combination with others, such as a number of protein mappings, genome location and amino acid composition will help the user to select candidate proteotypic peptides for a targeted proteomics (SRM, Selected Reaction Monitoring) experiment.
Concerning those cases where a selected protein of interest is not observed in the selected build, the PeptideAtlas also provides the Predicted Suitability Score (PSS), a value resulting from the combination of different observability prediction algorithms based upon physico-chemical properties derived from the amino acid composition and previous training datasets as described in [42] .
The build that assembles the phosphoprotein enrichment experiments may be of great potential interest to study biological processes such as signal transduction, since it encompasses a number of kinases and phosphatases. A total of 421 different phosphopeptides were detected and allocated to 210 phosphoproteins. The largest number of phosphorylation sites occurs in S, 410 phosphopeptides contain, at least, one phosphorylation in S; 79 phosphopeptides contain, at least, one phosphorylation in T; and 10 phosphopeptides contain one phosphorylation in Y.
Conclusions
This C albicans PeptideAtlas build provides empirical identification evidence for 21,938 unique peptides including 421 phosphopeptides at a 0.24% peptide-level FDR that account for a high-confidence set (as defined in [14] ) of 2562 canonical proteins at a 1.2% protein-level FDR representing thus a significant advance in the proteomic characterization of C. albicans. Through the web interface, an important set of tools are made available to the scientific community, enabling a solid foundation to study different basic biological processes like dimorphism, signal transduction, apoptosis and the interaction with the human host. Furthermore, its value as a resource for proteotypic peptide selection is of great potential interest for future SRM experiments.
The current version of the PeptideAtlas can be found at:https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/ buildDetails?atlas_build_id=323and the version including PTM results at:https://db.systemsbiology.net/sbeams/cgi/ PeptideAtlas/buildDetails?atlas_build_id=324.
